Reacquisition of RAI uptake in RAI-refractory metastatic thyroid cancers by pretreatment with the MEK inhibitor selumetinib.
Alan Loh Ho
Consultant or Advisory Role - AstraZeneca
Research Funding - AstraZeneca
Rebecca Leboeuf
No relevant relationships to disclose
Ravinder K. Grewal
No relevant relationships to disclose
Eric Jeffrey Sherman
No relevant relationships to disclose
Desiree Deandreis
No relevant relationships to disclose
Keith S. Pentlow
No relevant relationships to disclose
Robert Michael Tuttle
Consultant or Advisory Role - AstraZeneca (U)
Matthew G. Fury
No relevant relationships to disclose
Julio Cezar M. Ricarte-Filho
No relevant relationships to disclose
David G. Pfister
Research Funding - AstraZeneca
Steven M. Larson
Consultant or Advisory Role - ACR Image Metrix; Cougar Biotechnology; ImaginAb; Millennium; Perceptive Informatics; Senior Scientific LLC
James A. Fagin
No relevant relationships to disclose